Discover 1,283 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,283
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
for
Neoplasms
Location: Denver CO, West Valley City UT, Dallas TX, Tyler TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06551142
Phase 1, Recruiting
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
for
Cancer, Cancer, Lung
Location: Denver CO, Dallas TX, Los Angeles CA, Newport Beach CA,
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05948865
Phase 1, Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Denver CO, West Valley City UT, Irving TX, Austin TX,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase 1, Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Denver CO, Maple Grove MN, Columbia MO, Tyler TX,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase 2, Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Denver CO, Iowa City IA, Madison WI, Duarte CA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Denver CO, Salt Lake City UT, Oklahoma City OK,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase 1, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Denver CO, Phoenix AZ, Gilbert AZ, Tucson AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for
RSV Infection
Location: Aurora CO, Grand Island NE, Salt Lake City UT,
Sponsor: Pfizer
Sex: All
Age: 0+
Code: NCT06866405
Phase 3, Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Location: Aurora CO, St Louis MO, London, Atlanta GA, Toronto,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01522183
Recruiting
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
for
Colorectal Carcinoma
Location: Aurora CO
Sponsor: University of Kansas Medical Center
Sex: All
Age: 45 - 70+
Code: NCT06682650
Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
for
Hemophilia B
Location: Aurora CO, Phoenix AZ, Dallas TX, Los Angeles CA,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 2+
Code: NCT06379789
Phase 1, Phase 2, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
for
Hemophilia A
Location: Aurora CO, Minneapolis MN, Iowa City IA, Orange CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416604
Phase 3, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
for
Hemophilia A
Location: Aurora CO, Iowa City IA
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416526
Phase 3, Recruiting
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer